Siemens denies report it may cut 20,000 jobs
MUNICH/BERLIN (Reuters) – German engineering giant Siemens (SIEGn.DE) said a report by monthly Manager Magazin that it could cut 20,000 jobs as part of its Vision 2020+ strategy was “completely…
U.S.-China trade talks end with no breakthrough as tariffs kick in
WASHINGTON/BEIJING (Reuters) – U.S. and Chinese officials ended two days of talks on Thursday with no major breakthrough as their trade war escalated with activation of another round of dueling…
British Airways, Air France halting flights to Iran from next month
LONDON/PARIS (Reuters) – British Airways and Air France said on Thursday they would halt flights to Iran from September for business reasons, months after U.S. President Donald Trump announced he…
Alibaba revenue beats, but investments prolong margin squeeze
BEIJING (Reuters) – Alibaba Group Holding Ltd (BABA.N), China’s biggest e-commerce firm, topped first-quarter revenue estimates on Thursday, but said investments in its food delivery business would continue to weigh…
U.S., China escalate trade war, impose more tariffs
BEIJING/WASHINGTON (Reuters) – The United States and China escalated their acrimonious trade war on Thursday, implementing punitive 25 percent tariffs on $16 billion worth of each other’s goods. FILE PHOTO:…
U.S. health secretary says agency can eliminate drug rebates
WASHINGTON (Reuters) – U.S. Health and Human Services Secretary Alex Azar said it was within his agency’s power to eliminate rebates on prescription drug purchases, a key element of the…
Militia threat hampers Ebola fight in Congo as disease kills 47
GENEVA (Reuters) – Militia violence in Democratic Republic of Congo has prevented aid workers from reaching some potential cases in an outbreak of Ebola that has so far killed 47…
U.S. tariffs to stay on Turkey, Qatar offers Ankara aid
ISTANBUL/WASHINGTON (Reuters) – The United States on Wednesday ruled out removing steel tariffs that have contributed to a currency crisis in Turkey even if Ankara frees a U.S. pastor, as…
Long-acting injection a shot in the arm for GSK’s HIV business
LONDON (Reuters) – A long-acting injection developed by GlaxoSmithKline (GSK.L) and given once a month has proved as effective as standard daily pills for controlling the AIDS virus, lifting prospects…
Thyssenkrupp needs new strategy, targets not enough: investor
DUESSELDORF (Reuters) – Thyssenkrupp (TKAG.DE) needs a broad overhaul in strategy carried about by a new external chief executive, as mid-term targets announced this week will not be enough to…